Cigna Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $301K | Hold |
1,395
| – | – | 0.04% | 358 |
|
|
2026
Q1 | $256K | Hold |
1,395
| – | – | 0.04% | 378 |
|
|
2025
Q4 | $245K | Sell |
1,395
-62
| -4% | -$10.1K | 0.04% | 404 |
|
|
2025
Q3 | $204K | Buy |
+1,457
| New | +$197K | 0.03% | 460 |
|
|
2025
Q1 | – | Sell |
-1,494
| Closed | -$228K | – | 442 |
|
|
2024
Q4 | $228K | Hold |
1,494
| – | – | 0.04% | 405 |
|
|
2024
Q3 | $289K | Sell |
1,494
-30
| -2% | -$6.28K | 0.05% | 356 |
|
|
2024
Q2 | $353K | Hold |
1,524
| – | – | 0.07% | 302 |
|
|
2024
Q1 | $329K | Sell |
1,524
-20
| -1% | -$4.68K | 0.06% | 314 |
|
|
2023
Q4 | $400K | Sell |
1,544
-4
| -0.3% | -$982 | 0.08% | 257 |
|
|
2023
Q3 | $398K | Sell |
1,548
-195
| -11% | -$52.2K | 0.09% | 231 |
|
|
2023
Q2 | $497K | Sell |
1,743
-13
| -0.7% | -$3.87K | 0.09% | 218 |
|
|
2023
Q1 | $488K | Sell |
1,756
-43
| -2% | -$11.9K | 0.1% | 217 |
|
|
2022
Q4 | $498K | Buy |
1,799
+1
| +0.1% | +$282 | 0.1% | 207 |
|
|
2022
Q3 | $480K | Sell |
1,798
-94
| -5% | -$20K | 0.11% | 197 |
|
|
2022
Q2 | $386K | Sell |
1,892
-686
| -27% | -$140K | 0.08% | 267 |
|
|
2022
Q1 | $542K | Sell |
2,578
-785
| -23% | -$171K | 0.07% | 291 |
|
|
2021
Q4 | $806K | Sell |
3,363
-1,323
| -28% | -$340K | 0.06% | 259 |
|
|
2021
Q3 | $1.33M | Sell |
4,686
-121
| -3% | -$39.7K | 0.1% | 180 |
|
|
2021
Q2 | $1.67M | Sell |
4,807
-763
| -14% | -$231K | 0.12% | 154 |
|
|
2021
Q1 | $1.56M | Buy |
5,570
+129
| +2% | +$34.8K | 0.11% | 161 |
|
|
2020
Q4 | $1.33M | Buy |
5,441
+163
| +3% | +$42K | 0.1% | 172 |
|
|
2020
Q3 | $1.5M | Sell |
5,278
-363
| -6% | -$101K | 0.14% | 140 |
|
|
2020
Q2 | $1.51M | Sell |
5,641
-1,777
| -24% | -$534K | 0.14% | 143 |
|
|
2020
Q1 | $2.35M | Sell |
7,418
-3,831
| -34% | -$1.16M | 0.3% | 70 |
|
|
2019
Q4 | $3.02M | Sell |
11,249
-660
| -6% | -$183K | 0.32% | 64 |
|
|
2019
Q3 | $3.56M | Buy |
11,909
+253
| +2% | +$58.9K | 0.37% | 52 |
|
|
2019
Q2 | $2.77M | Buy |
11,656
+13
| +0.1% | +$3K | 0.3% | 66 |
|
|
2019
Q1 | $2.75M | Buy |
11,643
+3,247
| +39% | +$1.02M | 0.3% | 66 |
|
|
2018
Q4 | $2.53M | Buy |
8,396
+39
| +0.5% | +$12.4K | 0.21% | 68 |
|
|
2018
Q3 | $2.54M | Sell |
8,357
-4,839
| -37% | -$1.67M | 0.2% | 74 |
|
|
2018
Q2 | $3.83M | Buy |
13,196
+3,464
| +36% | +$974K | 0.28% | 48 |
|
|
2018
Q1 | $2.67M | Sell |
9,732
-126
| -1% | -$39.1K | 0.18% | 81 |
|
|
2017
Q4 | $3.14M | Sell |
9,858
-356
| -3% | -$114K | 0.21% | 68 |
|
|
2017
Q3 | $3.2M | Sell |
10,214
-1,283
| -11% | -$380K | 0.21% | 64 |
|
|
2017
Q2 | $3.12M | Sell |
11,497
-3,351
| -23% | -$886K | 0.21% | 65 |
|
|
2017
Q1 | $4.06M | Buy |
14,848
+6,683
| +82% | +$1.89M | 0.28% | 49 |
|
|
2016
Q4 | $2.31M | Buy |
+8,165
| New | +$2.42M | 0.25% | 79 |
|
Other funds holding BIIB
Cigna Investments's BIIB Position: Q2 2026 in Review
Cigna Investments held its Biogen (BIIB) position steady in Q2 2026 at 1,395 shares worth $301K. The position accounts for 0.04% of the portfolio, ranked #358.
Cigna Investments first reported a position in BIIB in Q4 2016 and has held it in 37 quarters since. The position peaked at $4.06M in Q1 2017. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Cigna Investments held 1,395 shares of Biogen worth $301K as of Q2 2026.
- Cigna Investments left its Biogen share count unchanged in Q2 2026.
- Biogen made up 0.04% of Cigna Investments's portfolio in Q2 2026, its #358 holding.
- Cigna Investments first reported a position in Biogen in Q4 2016 and has held it in 37 quarters since.
- Cigna Investments's Biogen position peaked at $4.06M in Q1 2017.
- 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.